Benchmark reiterates Genius Sports stock rating on NFL data deals
Benchmark reiterates Genius Sports stock rating on NFL data deals
Archived explainer. For the current picture see today's GENI page.
GENIUS SPORTS LTD (GENI) is up +4.52% in the latest session. Our newswire has captured 1 story on GENI across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 56/100).
GENI stock rose 4.52% to $8.32 on Friday, driven by a combination of analyst activity and positive market momentum. The stock opened with a 1.1% gap up and climbed further during the session, reaching a high of $8.34. Recent analyst upgrades and price target increases have contributed to the upward move.
Benchmark reiterated its Genius Sports stock rating following new NFL data deals, reinforcing confidence in the company's ability to expand its sports data offerings. This came alongside a series of analyst upgrades from major firms including Guggenheim, Macquarie, Oppenheimer, Needham, and BTIG. All five maintained their Buy or Outperform ratings and raised price targets, with four of them setting $12 as a new target and one setting $10. These actions signal continued optimism about the company's strategic direction and growth potential.
The stock's performance was also supported by strong intraday momentum. After opening at $8.05, the stock climbed steadily throughout the morning before consolidating near its high. The session low of $7.90 was quickly recovered, and the stock closed near its high. The volume of 0.5 million shares, while below the 3-month daily average, was sufficient to support the price action.
GENI has a market cap of $2.0 billion and remains unprofitable, with an EPS of -0.68 over the trailing twelve months. However, revenue growth has been robust, rising 41.5% TTM. The stock has a beta of 1.88, indicating higher volatility than the broader market. The 52-week range of $3.83 to $13.73 shows a wide price swing, and the stock hit 14 fresh 52-week highs on August 28, 2026. The recent price action suggests a continuation of that upward trend.
While the stock has shown strong short-term momentum, investors should monitor the broader analyst coverage and any upcoming corporate developments. No earnings date is provided, but continued analyst activity will likely remain a key factor in the stock's near-term direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Benchmark reiterates Genius Sports stock rating on NFL data deals
More on GENI: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier GENI move explainers: 2026-09-01 · 2026-08-31 · 2026-08-28 · 2026-08-26